The Evidence Is In and Has Been for Years
Find out how the ABLATE studies set the standard and hold strong where is counts
100% Confidence in Closure
100% Closure. Zero Leaks. Zero SAEs at 30 Days.
BoxX-NoAF Clinical Trial Now Enrolling
This trial aims to determine if a BoxX surgical ablation and LAA exclusion during planned heart surgery is safe and effective to reduce new-onset Afib in patients without a history of Afib but have risk factors for developing Afib
LAA Management + Surgical Ablation
A lifetime of impact for CABG patients
Introducing the cryoXT™ Probe
The new cryoXT probe harnesses the power of cryoICE® technology for a non-opioid approach to amputation pain management
0
Patients Served with Ablation Worldwide
0
AtriClip Devices Sold Worldwide
U.S. NEWS
AtriCure Reports First Quarter 2026 Financial Results
REDUCING GLOBAL AFIB
What is Afib, and how does it affect heart performance?
CAREERS
Interested in joining our mission focused on healing the lives of those affected by Afib and pain after surgery?
THERAPY INNOVATION
Post-Operative Pain Management: A non-opioid solution
PM-US-0301W-0128-G
© 2026 Atricure, Inc. All Rights Reserved.
BoxX-NoAF Clinical Trial
Duration: 1:
What is Cryo Nerve Block Therapy?
Duration: 00:26
LAA Electrical Isolation
Duration: 00:51
Cryo Nerve Block for Post-Op Pain Management
Duration: 00:37
social media channels to keep updated on the latest at AtriCure.